A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/18694678

Download in:

View as

General Info

PMID
18694678